← Evidence map

ArticleCancers2024

First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL.

Adolfo E Diaz Duque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39594812